Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Jeffrey S Wolf"'
Autor:
Clara Lehmann, Mark Lafferty, Alfredo Garzino-Demo, Norma Jung, Pia Hartmann, Gerd Fätkenheuer, Jeffrey S Wolf, Jan van Lunzen, Fabio Romerio
Publikováno v:
PLoS ONE, Vol 5, Iss 6, p e11110 (2010)
Circulating plasmacytoid dendritic cells (pDC) decline during HIV-1 infection, but at the same time they express markedly higher levels of interferon alpha (IFNalpha), which is associated with HIV-1 disease progression. Here we show an accumulation o
Externí odkaz:
https://doaj.org/article/088f4d9b73ee42e3aebfda86950ecd29
Autor:
Neha B. Amin, Kelly M. Bridgham, Jessica P. Brown, Kelly F. Moyer, Rodney J. Taylor, Jeffrey S. Wolf, Matthew E. Witek, Jason K. Molitoris, Ranee Mehra, Kevin J. Cullen, John C. Papadimitriou, Prashant Raghavan, Kyle M. Hatten
Publikováno v:
OTO Open, Vol 7, Iss 1, Pp n/a-n/a (2023)
Abstract Objectives To survey academic and community physician preferences regarding the virtual multidisciplinary tumor board (MTB) for further improvement and expansion. Study Design This anonymous 14‐question survey was sent to individuals that
Externí odkaz:
https://doaj.org/article/225bb4986ee9440cb58ec3d8e19d1efc
Autor:
Michael J. Brenner MD, Jared A. Shenson MD, Austin S. Rose MD, MBA, Tulio A. Valdez MD, MSc, Masayoshi Takashima MD, Omar G. Ahmed MD, Philip A. Weissbrod MD, Robert S. Hong MD, PhD, Hamid Djalilian MD, Jeffrey S. Wolf MD, Robert J. Morrison MD, Peter L. Santa Maria MBBS, PhD, Isaac D. Erbele MD
Publikováno v:
OTO Open, Vol 5 (2021)
Objectives To evaluate new drugs and devices relevant to otolaryngology–head and neck surgery that were approved by the US Food and Drug Administration (FDA) in 2020. Data Sources Publicly available device and therapeutic approvals from ENT (ear, n
Externí odkaz:
https://doaj.org/article/90267ef6f02d4d93a83c75aa4a0c7a8e
Autor:
Ariel E. Pollock, Danielle Arons, Gregory S. Alexander, David Alicia, Kayla M. Birkman, Jason K. Molitoris, Ranee Mehra, Kevin J. Cullen, Kyle M. Hatten, Rodney J. Taylor, Jeffrey S. Wolf, William F. Regine, Matthew E. Witek
Publikováno v:
Head & Neck. 45:1088-1096
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09d5a024f96f67ccca4b7e26103ea224
https://doi.org/10.1002/hed.27308
https://doi.org/10.1002/hed.27308
Autor:
Ranee Mehra, John C. Papadimitriou, Jeffrey S. Wolf, Reju Joy, Kyle M. Hatten, Neha P. Amin, Rodney J. Taylor, Robert E. Morales, Donita Dyalram, Kevin J. Cullen, Joshua Adam Thompson, Matthew E Witek, Robert A. Ord, Joshua E. Lubek, Jason K. Molitoris
Publikováno v:
Otolaryngology--Head and Neck Surgery
Objective The study aimed to assess the impact of the coronavirus disease 2019 (COVID-19) pandemic on head and neck oncologic care at a tertiary care facility. Study Design This was a cross-sectional study conducted between March 18, 2020, and May 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71fa46239dee9a99c1b6aa379ecf4f01
https://doi.org/10.1177/01945998211004544
https://doi.org/10.1177/01945998211004544
Autor:
Neha Amin, Joshua Thompson, Olga Goloubeva, Matthew Witek, Rodney J. Taylor, Jeffrey S. Wolf, Kelly Moyer, Ranee Mehra, Kyle M. Hatten
Publikováno v:
ORL; journal for oto-rhino-laryngology and its related specialties. 84(6)
Introduction: The study objective was to identify practice patterns in oropharyngeal cancer management from 2010 to 2016 among human papillomavirus (HPV)-associated and non-HPV-associated oropharyngeal squamous-cell carcinoma (OPSCC) patients. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f21f27d708d94abe6fbaa137061158ae
https://pubmed.ncbi.nlm.nih.gov/36067748
https://pubmed.ncbi.nlm.nih.gov/36067748
Autor:
Andrea Hebert, Jeffrey S. Wolf, John C. Papadimitriou, Robert E. Morales, Rodney J. Taylor, Neila L. Kline, Joseph A. Califano, Kavita Bhatnagar
Publikováno v:
International forum of allergyrhinologyREFERENCES. 12(3)
Background Chronic rhinosinusitis (CRS) causes a great deal of morbidity. There are a multitude of causal factors, though their precise contribution to symptom severity has yet to be defined. We hypothesized that exposure to both primary and secondha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6851e3c1c42efff68817c8a95dc483d2
https://pubmed.ncbi.nlm.nih.gov/34510792
https://pubmed.ncbi.nlm.nih.gov/34510792
Autor:
Rodney J. Taylor, Joshua E. Lubek, Jason K. Molitoris, Jeffrey S. Wolf, Joshua A. Thompson, Reju Joy, Ranee Mehra, Matthew E. Witek, Kyle M. Hatten
Publikováno v:
Clinical Cancer Research. 26:PO-017
Objective: The study aimed to assess the impact of the coronavirus (COVID-19) pandemic on head and neck oncologic care at a tertiary care hospital. The pandemic caused by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has led to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6aea909bc9c9fed95a5c2db7a8ec96b3
https://doi.org/10.1158/1557-3265.covid-19-po-017
https://doi.org/10.1158/1557-3265.covid-19-po-017
Autor:
Dan P. Zandberg, Scott E. Strome, Joshua E. Lubek, Rodney J. Taylor, Lisa M. Schumaker, Jeffrey S. Wolf, Robert E. Morales, Kevin J. Cullen, Robert A. Ord, Ann B. Zimrin, Olga Goloubeva, Mohan Suntharalingam, Sandy Liu
Publikováno v:
Head & Neck. 38:564-572
Background Racial outcome disparities have been observed in head and neck squamous cell carcinoma (HNSCC) with diminished survival for black patients compared with white patients. Methods We retrospectively analyzed 1318 patients with primary HNSCC t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79fff99795b9d5d2562a2f211aac3936
https://doi.org/10.1002/hed.23933
https://doi.org/10.1002/hed.23933
Autor:
Rodney J. Taylor, Kevin J. Cullen, Dan P. Zandberg, Sandra Rollins, Jeffrey S. Wolf, Lisa M. Schumaker, Dean L. Mann, Ming Tan, Mohan Suntharalingam, Joshua E. Lubek, Martin J. Edelman, Ann B. Zimrin, John C. Papadimitriou, Olga Goloubeva, Robert A. Ord, Scott E. Strome, Robert E. Morales
Publikováno v:
Cancer Immunology, Immunotherapy. 64:367-379
We conducted a phase I dose escalation study to evaluate the safety and immunologic response to peptide immunomodulatory vaccines GL-0810 (HPV16) and GL-0817 (MAGE-A3) in HPV16 and MAGE-A3-positive RM–SCCHN patients, respectively. Three dose levels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6b5b346d2776dbcc9f0d06e52ead0fc
https://doi.org/10.1007/s00262-014-1640-x
https://doi.org/10.1007/s00262-014-1640-x